Literature DB >> 8155032

The correction of high myopia using the excimer laser.

J Heitzmann1, P S Binder, B S Kassar, L T Nordan.   

Abstract

OBJECTIVE: To determine the safety and efficacy of excimer laser photoablation as a treatment to correct high myopia that is defined as a spherical equivalent refractive error greater than -8.00 diopters (D).
DESIGN: Using a multizone (4.0-, 5.0-, and 6.0-mm) photorefractive keratectomy protocol for correction of high myopia, 23 eyes in 18 patients were treated at one clinical center with an excimer laser (VISX Inc, Santa Clara, Calif). Preoperative spherical equivalent refractions ranged from -8.00 to -19.50 D (mean +/- SD, -11.83 +/- 2.92 D); the mean attempted ablation depth was 93.0 +/- 20.2 microns.
RESULTS: At the last postoperative examination (mean +/- SD, 7.5 +/- 3.7 months), the mean +/- SD spherical equivalent refraction was -1.09 +/- 2.08 D, including results from two repeated procedures; visual acuity in 52% of the eyes was 20/40 or better uncorrected; 65% of the eyes improved or did not change best corrected acuity, whereas two eyes lost 2 Snellen lines; 39% of the eyes were +/- 1.00 D; and 65% were +/- 2.00 D of attempted correction. Corneal haze (corneal clarity score of > or = 1.5) was observed in 47% of the eyes at some time postoperatively.
CONCLUSIONS: Photorefractive keratectomy for high myopia was found to be not nearly as efficient or predictable as it is for low myopia. A greater incidence of regression of refractive effect and corneal haze were noted in these cases compared with reported studies of low to moderate myopia. A multizone approach to reduce ablation depth during photorefractive keratectomy for myopia that is greater than 8.00 D does not appear to prevent subsequent haze or refractive regression.

Entities:  

Mesh:

Year:  1993        PMID: 8155032     DOI: 10.1001/archopht.1993.01090120049021

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  23 in total

1.  Laser intrastromal keratomileusis for high myopia and myopic astigmatism.

Authors:  P I Condon; M Mulhern; T Fulcher; A Foley-Nolan; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1997-03       Impact factor: 4.638

2.  Differential CT features of infectious pneumonia versus bronchioloalveolar carcinoma (BAC) mimicking pneumonia.

Authors:  Tae Hoon Kim; Sang Jin Kim; Young Hoon Ryu; Soo Yoon Chung; Jae Seung Seo; Young Jin Kim; Byoung Wook Choi; Sun Hwa Lee; Sang Ho Cho
Journal:  Eur Radiol       Date:  2006-01-18       Impact factor: 5.315

3.  Excimer retreatment for scarring and regression after photorefractive keratectomy for myopia.

Authors:  G Sutton; R S Kalski; M A Lawless; C Rogers
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

4.  Effect of ablation profile on wound healing and visual performance 1 year after excimer laser photorefractive keratectomy.

Authors:  M C Corbett; S Verma; D P O'Brart; K M Oliver; G Heacock; J Marshall
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

5.  Excimer laser PRK and corticosteroid induced IOP elevation: the tip of an emerging iceberg?

Authors:  P S Phelan; C N McGhee; I G Bryce
Journal:  Br J Ophthalmol       Date:  1994-10       Impact factor: 4.638

6.  Excimer laser treatment for high and extreme myopia.

Authors:  H R Taylor; C A Carson
Journal:  Trans Am Ophthalmol Soc       Date:  1994

7.  Laser In Situ keratomileusis (LASIK) for the treatment of low moderate, and high myopia.

Authors:  R L Lindstrom; D R Hardten; Y R Chu
Journal:  Trans Am Ophthalmol Soc       Date:  1997

8.  Photorefractive keratectomy for anisometropic amblyopia in children.

Authors:  Evelyn A Paysse
Journal:  Trans Am Ophthalmol Soc       Date:  2004

9.  Visual quality after wavefront-guided LASIK for myopia.

Authors:  Hyojin Kim; Choun-Ki Joo
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

10.  [A prospective intraindividual comparison between laser in situ keratomileusis and laser subepithelial keratectomy for myopia. 1-year follow-up results].

Authors:  A Tietjen; C Müller; W Sekundo
Journal:  Ophthalmologe       Date:  2008-10       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.